STRIVE

Welcome to the Brand page for “STRIVE”, which is offered here for Pharmaceutical preparations containing synthetic adeno-associated virus capsids for delivery of genetic treatments to biological cells in living patients for use in the treatment of vascular, lung, eye, brain, liver, heart, and muscle diseases and conditions and genetic diseases;scientific research and design and development of novel gene therapy vectors and therapeutics derived therefrom for vascular and lung, eye, brain, liver, heart, and muscle diseases and conditions and genetic diseases;.

Its status is currently believed to be active. Its class is unavailable. “STRIVE” is believed to be currently owned by “STRIDEBIO, INC.”